CorMedix
CRMD
HK$91.37
Share price
-2.84%
Change (1 day)
149.89%
Change (1 year)
Categories
Revenue for CorMedix (CRMD)
Revenue in 2025 (TTM): HK$0.64 Billion
According to CorMedix's latest financial reports the company's current revenue (TTM 
) is HK$0.64 Billion. In 2024 the company made a revenue of HK$0.33 Billion an increase over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for CorMedix from 2009 to 2025
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2025 (TTM) | HK$0.64 B | 90.13% |
| 2024 | HK$0.33 B | |
| 2023 | N/A | -100% |
| 2022 | HK$0.51 M | -65.67% |
| 2021 | HK$1.48 M | -19.72% |
| 2020 | HK$1.85 M | -15.93% |
| 2019 | HK$2.2 M | -34.45% |
| 2018 | HK$3.36 M | 30.81% |
| 2017 | HK$2.57 M | 48.06% |
| 2016 | HK$1.73 M | 6.7% |
| 2015 | HK$1.62 M | 10.94% |
| 2014 | HK$1.46 M | 9361.56% |
| 2013 | HK$0.01 M | |
| 2012 | N/A | |
| 2011 | N/A | |
| 2010 | N/A | |
| 2009 | N/A |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Becton Dickinson BDX | HK$163.79 B | 25,176.84% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | HK$7.30 B | 1,026.90% | 🇺🇸 USA |
 Utah Medical Products UTMD | HK$0.30 B | -52.43% | 🇺🇸 USA |